fascinated by the human brain |
interested in movement disorders, cognition, MEG, neurodiversity and coffee.
team leader @Karolinska
journals.sagepub.com/doi/10.1177/...
journals.sagepub.com/doi/10.1177/...
👩🔬👨🔬 We investigate how parenthood affects scientific productivity and impact — and find that the impact is far from equal for mothers and fathers.
👩🔬👨🔬 We investigate how parenthood affects scientific productivity and impact — and find that the impact is far from equal for mothers and fathers.
We find that MEG can be used to quantify the "off-target" effects of dopamine therapies in people living with #Parkinson's disease
#neuroskyence
🧵👇
(1/9)
We find that MEG can be used to quantify the "off-target" effects of dopamine therapies in people living with #Parkinson's disease
#neuroskyence
🧵👇
(1/9)
I have recently commenced a project at Aarhus University, Denmark, called: Re-integration of the cerebellum. Therefore, I am recruiting a Postdoc for 2½ years to begin September 1st 2025. The deadline is March 20th 2025.
international.au.dk/about/profil...
I have recently commenced a project at Aarhus University, Denmark, called: Re-integration of the cerebellum. Therefore, I am recruiting a Postdoc for 2½ years to begin September 1st 2025. The deadline is March 20th 2025.
international.au.dk/about/profil...
www.medrxiv.org/content/10.1...
We use a MEG with a PLS-neuromaps "search" of off-target cortical effects of dopamine therapies in patients with #Parkinson's disease
A strong beta-rhythmic activation of dopamine-rich cortices in response to medication ▶️ worse clinical response
www.medrxiv.org/content/10.1...
We use a MEG with a PLS-neuromaps "search" of off-target cortical effects of dopamine therapies in patients with #Parkinson's disease
A strong beta-rhythmic activation of dopamine-rich cortices in response to medication ▶️ worse clinical response